BrightGene Bio (China) Price on May 11, 2023
| 688166 Stock | 30.92 1.21 4.07% |
Below is the normalized historical share price chart for BrightGene Bio Medical extending back to November 08, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BrightGene Bio stands at 30.92, as last reported on the 28th of January, with the highest price reaching 31.17 and the lowest price hitting 29.99 during the day.
If you're considering investing in BrightGene Stock, it is important to understand the factors that can impact its price. At this point, BrightGene Bio is very steady. BrightGene Bio Medical secures Sharpe Ratio (or Efficiency) of 0.0268, which signifies that the company had a 0.0268 % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for BrightGene Bio Medical, which you can use to evaluate the volatility of the firm. Please confirm BrightGene Bio's Risk Adjusted Performance of 0.0013, mean deviation of 2.35, and Standard Deviation of 3.49 to double-check if the risk estimate we provide is consistent with the expected return of 0.0935%.
The current year's Other Stockholder Equity is expected to grow to about 21.5 M, whereas Total Stockholder Equity is forecasted to decline to about 1.4 B. . BrightGene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 30.7579 | 50 Day MA 31.0172 | Beta 0.386 |
BrightGene |
Sharpe Ratio = 0.0268
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | 688166 | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.48 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average BrightGene Bio is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BrightGene Bio by adding it to a well-diversified portfolio.
Price Book 5.553 | Enterprise Value Ebitda 70.2095 | Price Sales 10.522 | Shares Float 259.2 M | Wall Street Target Price 44.21 |
BrightGene Bio Valuation on May 11, 2023
It is possible to determine the worth of BrightGene Bio on a given historical date. On May 11, 2023 BrightGene was worth 21.26 at the beginning of the trading date compared to the closed value of 21.16. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of BrightGene Bio stock. Still, in general, we apply an absolute valuation method to find BrightGene Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of BrightGene Bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against BrightGene Bio's related companies.
| Open | High | Low | Close | Volume | |
| 20.84 | 21.73 | 20.80 | 21.25 | 5,272,320 | |
05/11/2023 | 21.26 | 21.47 | 20.96 | 21.16 | 2,389,773 |
| 21.10 | 21.58 | 20.96 | 20.96 | 1,761,017 |
| Backtest BrightGene Bio | | | BrightGene Bio History | | | BrightGene Bio Valuation | Previous | Next |
BrightGene Bio Trading Date Momentum on May 11, 2023
| On May 12 2023 BrightGene Bio Medical was traded for 20.96 at the closing time. The highest price during the trading period was 21.58 and the lowest recorded bid was listed for 20.96 . The volume for the day was 1.8 M. This history from May 12, 2023 contributed to the next trading day price decline. The daily price change to the next closing price was 0.95% . The overall trading delta to the current price is 1.32% . |
BrightGene Bio Medical Fundamentals Correlations and Trends
By evaluating BrightGene Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among BrightGene Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. BrightGene financial account trend analysis is a perfect complement when working with valuation or volatility modules.About BrightGene Bio Stock history
BrightGene Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BrightGene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BrightGene Bio Medical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BrightGene Bio stock prices may prove useful in developing a viable investing in BrightGene Bio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 485.8 M | 340.7 M | |
| Net Income Applicable To Common Shares | 275.6 M | 141.5 M |
BrightGene Bio Quarterly Net Working Capital |
|
BrightGene Bio Stock Technical Analysis
BrightGene Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
BrightGene Bio Period Price Range
Low | January 28, 2025
| High |
0.00 | 0.00 |
BrightGene Bio Medical cannot be verified against its exchange. Please verify the symbol is currently traded on Shanghai Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
BrightGene Bio January 28, 2025 Market Strength
Market strength indicators help investors to evaluate how BrightGene Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BrightGene Bio shares will generate the highest return on investment. By undertsting and applying BrightGene Bio stock market strength indicators, traders can identify BrightGene Bio Medical entry and exit signals to maximize returns
BrightGene Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BrightGene Bio's price direction in advance. Along with the technical and fundamental analysis of BrightGene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BrightGene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0013 | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.26) | |||
| Treynor Ratio | (0.02) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for BrightGene Stock analysis
When running BrightGene Bio's price analysis, check to measure BrightGene Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrightGene Bio is operating at the current time. Most of BrightGene Bio's value examination focuses on studying past and present price action to predict the probability of BrightGene Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrightGene Bio's price. Additionally, you may evaluate how the addition of BrightGene Bio to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |